TapewireFind a company

person · Reporting owner

Eldracher Deborah DiSanzo

Disclosed activity across 3 companies

Tapewire entity
123032
SEC CIK
0001661251

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
BEST BUY CO INCBBY · Entity 3305President, Best Buy HealthOctober 17, 2022October 18, 2022
Lifeward Ltd.RWLK · Entity 7620DirectorApril 30, 2018May 02, 2018
NOVANTA INCNOVT · Entity 3857DirectorJanuary 03, 2022January 05, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BEST BUY CO INC

Report date October 17, 2022 · Filed October 18, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect21,412 Reported balance After 2022-10-17 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2022-10-17 · Sale · Disposed 28 · Balance 21,412

F1: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person.

F2: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c).

Filing footnotes · ownership attribution and instrument terms

F1: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person.

F2: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c).

Lifeward Ltd.

Report date April 30, 2018 · Filed May 02, 2018

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Ordinary Shares, par value NIS 0.01 per shareSEC Table I · non-derivativeIndirectESOP22,727 Reported balance After 2018-04-30 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2018-04-30 · Grant · Acquired 22,727 · Balance 22,727

F1: Represents 22,727 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on April 30, 2018 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant.

Filing footnotes · ownership attribution and instrument terms

F1: Represents 22,727 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on April 30, 2018 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant.

NOVANTA INC

Report date January 03, 2022 · Filed January 05, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect1,705 Reported balance After 2022-01-04 transaction · row 1
1 source row

Row 1 · 2022-01-04 · Exercise / conversion · Acquired 531 · Balance 1,705

F1: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2022, the RSUs were settled in Novanta Inc. common shares.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect0 Reported balance After 2022-01-04 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2022-01-04 · Exercise / conversion · Disposed 531 · Balance 0

F1: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2022, the RSUs were settled in Novanta Inc. common shares.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect359 Reported balance After 2022-01-03 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2022-01-03 · Grant · Acquired 359 · Balance 359

F2: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).

F3: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date.

Deferred Stock UnitsSEC Table II · derivative / convertible securityDirect2,064 Reported balance After 2022-01-03 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2022-01-03 · Grant · Acquired 359 · Balance 2,064

F4: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date.

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2022, the RSUs were settled in Novanta Inc. common shares.

F2: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).

F3: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date.

F4: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
October 17, 2022 Filed Oct 18, 2022 20:28 UTC BEST BUY CO INC BBY · Entity 3305 SaleCommon Stock 28 $64.58 $1,808.18
Disclosure

SEC source: 0001225208-22-011020 · doc4.xml · nonDerivative · entry 1

Eldracher Deborah DiSanzo · CIK 0001661251 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,412

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person.

F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c).

Read SEC document
September 21, 2022 Filed Sep 23, 2022 20:33 UTC BEST BUY CO INC BBY · Entity 3305 SaleCommon Stock 1,834 $71.58 $131,274.05
Disclosure

SEC source: 0001225208-22-010447 · doc4.xml · nonDerivative · entry 1

Eldracher Deborah DiSanzo · CIK 0001661251 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,169

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person.

F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c).

Read SEC document
March 22, 2022 Filed Mar 23, 2022 22:15 UTC BEST BUY CO INC BBY · Entity 3305 SaleCommon Stock 799 $99.06 $79,150.54
Disclosure

SEC source: 0001225208-22-005015 · doc4.xml · nonDerivative · entry 1

Eldracher Deborah DiSanzo · CIK 0001661251 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,606

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person.

Read SEC document
March 20, 2022 Filed Mar 22, 2022 21:52 UTC BEST BUY CO INC BBY · Entity 3305 GrantCommon Stock 7,610 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-004964 · doc4.xml · nonDerivative · entry 1

Eldracher Deborah DiSanzo · CIK 0001661251 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,405

F1 · shares: Restricted shares that will vest in three equal annual installments beginning one year from the grant date.

Read SEC document
March 09, 2022 Filed Mar 11, 2022 21:38 UTC BEST BUY CO INC BBY · Entity 3305 GrantCommon Stock 5,396 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-004545 · doc4.xml · nonDerivative · entry 1

Eldracher Deborah DiSanzo · CIK 0001661251 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,795

F1 · shares: Represents restricted shares earned pursuant to an award approved by the Issuer on March 20, 2021, which was subject to achievement of positive adjusted net earnings as of the end of any fiscal year during the term of the award (the 'Performance Condition'). Satisfaction of the Performance Condition was approved by the Compensation and Human Resources Committee of the Board of Directors on March 9, 2022. The restricted shares will vest in three equal annual installments beginning March 20, 2022.

F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c).

Read SEC document
January 04, 2022 Filed Jan 5, 2022 21:35 UTC NOVANTA INC NOVT · Entity 3857 Exercise / conversionRestricted Stock Units · Derivative 531 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-22-000874 · form4.xml · derivative · entry 2

Eldracher Deborah DiSanzo · CIK 0001661251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 531 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2022, the RSUs were settled in Novanta Inc. common shares.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2022, the RSUs were settled in Novanta Inc. common shares.

F1 · price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2022, the RSUs were settled in Novanta Inc. common shares.

F1 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2022, the RSUs were settled in Novanta Inc. common shares.

F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2022, the RSUs were settled in Novanta Inc. common shares.

Read SEC document
January 04, 2022 Filed Jan 5, 2022 21:35 UTC NOVANTA INC NOVT · Entity 3857 Exercise / conversionCommon Stock 531 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-22-000874 · form4.xml · nonDerivative · entry 1

Eldracher Deborah DiSanzo · CIK 0001661251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,705

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2022, the RSUs were settled in Novanta Inc. common shares.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:35 UTC NOVANTA INC NOVT · Entity 3857 GrantDeferred Stock Units · Derivative 359 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-22-000874 · form4.xml · derivative · entry 4

Eldracher Deborah DiSanzo · CIK 0001661251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,064

Underlying: Common Stock · 359 shares

Expires not disclosed

F4 · derivative.exercise_price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date.

F4 · price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date.

F4 · derivative.exercise_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date.

F4 · derivative.expiration_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:35 UTC NOVANTA INC NOVT · Entity 3857 GrantRestricted Stock Units · Derivative 359 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-000874 · form4.xml · derivative · entry 3

Eldracher Deborah DiSanzo · CIK 0001661251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 359

Underlying: Common Stock · 359 shares

Expires not disclosed

F2 · security: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).

F2 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).

F2 · derivative.exercise_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).

F3 · derivative.exercise_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date.

F2 · derivative.expiration_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).

F3 · derivative.expiration_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date.

Read SEC document
October 07, 2021 Filed Oct 12, 2021 20:34 UTC BEST BUY CO INC BBY · Entity 3305 SaleCommon Stock 14 $107.65 $1,507.04
Disclosure

SEC source: 0001225208-21-013087 · doc4.xml · nonDerivative · entry 1

Eldracher Deborah DiSanzo · CIK 0001661251 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,344

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person.

F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c).

Read SEC document
September 21, 2021 Filed Sep 22, 2021 20:58 UTC BEST BUY CO INC BBY · Entity 3305 SaleCommon Stock 1,776 $107.18 $190,346.35
Disclosure

SEC source: 0001225208-21-012508 · doc4.xml · nonDerivative · entry 1

Eldracher Deborah DiSanzo · CIK 0001661251 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,278

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person.

F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c).

Read SEC document
January 04, 2021 Filed Jan 6, 2021 21:43 UTC NOVANTA INC NOVT · Entity 3857 GrantDeferred Stock Units · Derivative 531 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-001018 · form4.xml · derivative · entry 4

Eldracher Deborah DiSanzo · CIK 0001661251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,705

Underlying: Common Stock · 531 shares

Expires not disclosed

F4 · derivative.exercise_price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date.

F4 · price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date.

F4 · derivative.exercise_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date.

F4 · derivative.expiration_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 21:43 UTC NOVANTA INC NOVT · Entity 3857 GrantRestricted Stock Units · Derivative 531 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-001018 · form4.xml · derivative · entry 3

Eldracher Deborah DiSanzo · CIK 0001661251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 531

Underlying: Common Stock · 531 shares

Expires not disclosed

F2 · security: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).

F2 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).

F2 · derivative.exercise_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).

F3 · derivative.exercise_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date.

F2 · derivative.expiration_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).

F3 · derivative.expiration_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 21:43 UTC NOVANTA INC NOVT · Entity 3857 Exercise / conversionRestricted Stock Units · Derivative 682 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-001018 · form4.xml · derivative · entry 2

Eldracher Deborah DiSanzo · CIK 0001661251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 682 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2021, the RSUs were settled in Novanta Inc. common shares.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2021, the RSUs were settled in Novanta Inc. common shares.

F1 · price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2021, the RSUs were settled in Novanta Inc. common shares.

F1 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2021, the RSUs were settled in Novanta Inc. common shares.

F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2021, the RSUs were settled in Novanta Inc. common shares.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 21:43 UTC NOVANTA INC NOVT · Entity 3857 Exercise / conversionCommon Stock 682 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-001018 · form4.xml · nonDerivative · entry 1

Eldracher Deborah DiSanzo · CIK 0001661251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,174

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 4, 2021, the RSUs were settled in Novanta Inc. common shares.

Read SEC document
September 20, 2020 Filed Sep 22, 2020 20:54 UTC BEST BUY CO INC BBY · Entity 3305 GrantCommon Stock 11,840 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-011741 · doc4.xml · nonDerivative · entry 1

Eldracher Deborah DiSanzo · CIK 0001661251 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,840

F1 · shares: Restricted shares that will vest in three equal annual installments beginning one year from the grant date.

Read SEC document
May 11, 2020 Filed May 12, 2020 20:44 UTC NOVANTA INC NOVT · Entity 3857 Exercise / conversionRestricted Stock Units · Derivative 492 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-016294 · form4.xml · derivative · entry 2

Disanzo Deborah · CIK 0001661251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 492 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On May 11, 2020, the RSUs were settled in Novanta Inc. common shares.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On May 11, 2020, the RSUs were settled in Novanta Inc. common shares.

F1 · price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On May 11, 2020, the RSUs were settled in Novanta Inc. common shares.

F1 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On May 11, 2020, the RSUs were settled in Novanta Inc. common shares.

F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On May 11, 2020, the RSUs were settled in Novanta Inc. common shares.

Read SEC document
May 11, 2020 Filed May 12, 2020 20:44 UTC NOVANTA INC NOVT · Entity 3857 Exercise / conversionCommon Stock 492 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-016294 · form4.xml · nonDerivative · entry 1

Disanzo Deborah · CIK 0001661251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 492

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On May 11, 2020, the RSUs were settled in Novanta Inc. common shares.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 22:39 UTC NOVANTA INC NOVT · Entity 3857 GrantDeferred Stock Units · Derivative 682 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-001236 · form4.xml · derivative · entry 2

Disanzo Deborah · CIK 0001661251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,174

Underlying: Common Stock · 682 shares

Expires not disclosed

F3 · derivative.exercise_price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date.

F3 · price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date.

F3 · derivative.exercise_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date.

F3 · derivative.expiration_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date.

Read SEC document
January 02, 2020 Filed Jan 6, 2020 22:39 UTC NOVANTA INC NOVT · Entity 3857 GrantRestricted Stock Units · Derivative 682 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-001236 · form4.xml · derivative · entry 1

Disanzo Deborah · CIK 0001661251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 682

Underlying: Common Stock · 682 shares

Expires not disclosed

F1 · security: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).

F1 · derivative.exercise_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).

F2 · derivative.exercise_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date.

F1 · derivative.expiration_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).

F2 · derivative.expiration_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date.

Read SEC document
May 09, 2019 Filed May 13, 2019 20:41 UTC NOVANTA INC NOVT · Entity 3857 GrantDeferred Stock Units · Derivative 492 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-19-018332 · form4.xml · derivative · entry 2

Disanzo Deborah · CIK 0001661251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 492

Underlying: Common Stock · 492 shares

Expires not disclosed

F3 · derivative.exercise_price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of Issuer common stock.

F3 · price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of Issuer common stock.

F3 · derivative.exercise_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of Issuer common stock.

F3 · derivative.expiration_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of Issuer common stock.

Read SEC document
May 09, 2019 Filed May 13, 2019 20:41 UTC NOVANTA INC NOVT · Entity 3857 GrantRestricted Stock Units · Derivative 492 $0.00 $0.00
Disclosure

SEC source: 0001127602-19-018332 · form4.xml · derivative · entry 1

Disanzo Deborah · CIK 0001661251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 492

Underlying: Common Stock · 492 shares

Expires not disclosed

F1 · security: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).

F1 · derivative.exercise_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).

F2 · derivative.exercise_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date.

F1 · derivative.expiration_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).

F2 · derivative.expiration_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date.

Read SEC document
April 30, 2018 Filed May 2, 2018 20:02 UTC Lifeward Ltd. RWLK · Entity 7620 GrantOrdinary Shares, par value NIS 0.01 per share 22,727 $0.00 $0.00
Disclosure

SEC source: 0001607962-18-000020 · wf-form4_152529133599383.xml · nonDerivative · entry 1

Disanzo Deborah · CIK 0001661251 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · ESOP

Disclosed balance after: 22,727

F1 · shares: Represents 22,727 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on April 30, 2018 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant.

Read SEC document
June 27, 2017 Filed Jun 29, 2017 12:16 UTC Lifeward Ltd. RWLK · Entity 7620 GrantOption (Right to buy) · Derivative 4,176 $0.00 Strike: $2.10 $0.00
Disclosure

SEC source: 0001628280-17-006791 · wf-form4_149873860066032.xml · derivative · entry 1

Disanzo Deborah · CIK 0001661251 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,176

Underlying: Ordinary Shares, par value NIS 0.01 per share · 4,176 shares

Expires 2027-06-27

F1 · derivative.exercise_date: Represents stock options granted under the ReWalk 2014 Equity Incentive Plan on June 27, 2017. The options become vested and exercisable in four equal quarterly installments starting three months following the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.